931100381	931100381	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
74802632	74802632	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
337882	337882	CD	B-NP	O
|	|	CC	I-NP	O
10/4/1998	10/4/1998	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-ADJP	O
?	?	.	O	O

CEREBROVASCULAR	CEREBROVASCULAR	NNP	B-NP	O
ACCIDENT	ACCIDENT	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/8/1998	3/8/1998	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/24/1998	5/24/1998	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
62	62	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
Latin	Latin	JJ	I-NP	O
American	American	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
awakening	awaken	VBG	B-VP	O
on	on	IN	B-PP	O
22	22	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
with	with	IN	B-PP	O
vertical	vertical	JJ	B-NP	O
diplopia	diplopia	NN	I-NP	O
,	,	,	O	O
imbalance	imbalance	NN	B-NP	O
,	,	,	O	O
falling	fall	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
weakness	weakness	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
,	,	,	O	O
?	?	.	O	O

left	left	RB	B-ADJP	O
greater	great	JJR	I-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
in	in	IN	I-PP	O
her	her	PRP$	B-NP	O
arms	arm	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
reports	report	NNS	I-NP	O
feeling	feel	VBG	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
speech	speech	NN	I-NP	O
was	be	VBD	B-VP	O
weak	weak	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
hoarse	hoarse	VB	B-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denied	deny	VBD	B-VP	O
having	have	VBG	I-VP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
swallowing	swallow	VBG	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
headaches	headache	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
visual	visual	JJ	B-NP	O
acuity	acuity	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hearing	hearing	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
facial	facial	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
or	or	CC	I-NP	O
sensory	sensory	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
illness	illness	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
hospitalized	hospitalize	VBN	I-VP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
April	April	NNP	I-NP	O
,	,	,	O	O
1997	1997	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Biaxin	Biaxin	NN	B-NP	B-protein
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Type	Type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Degenerative	Degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
cataract	cataract	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Obesity	Obesity	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Gastroesophageal	Gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O
?	?	.	O	O

sleep	sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
17	17	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.week	q.week	NN	I-NP	I-protein
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
70/30	70/30	CD	I-NP	O
134	134	CD	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
84	84	CD	B-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
CD	CD	NNP	B-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
KCl	KCl	NN	B-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Relafen	Relafen	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
amitriptyline	amitriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
reported	report	VBD	B-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
128/70	128/70	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
75	75	CD	I-NP	O
.	.	.	O	O

Obese	Obese	JJ	B-NP	O
middle	middle	JJ	I-NP	O
aged	aged	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
atraumatic	atraumatic	JJ	B-ADJP	O
,	,	,	O	O
normocephalic	normocephalic	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
morbid	morbid	JJ	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
active	active	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
healing	healing	JJ	I-NP	O
right	right	JJ	I-NP	O
shin	shin	NN	I-NP	O
superficial	superficial	JJ	I-NP	O
wound	wound	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
orientation	orientation	NN	B-NP	O
,	,	,	O	O
attention	attention	NN	B-NP	O
and	and	CC	I-NP	O
language	language	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Speech	Speech	NN	B-NP	O
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
clearly	clearly	RB	I-ADJP	O
hoarse	hoarse	JJ	I-ADJP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
right	right	JJ	B-NP	O
pupil	pupil	NN	I-NP	O
irregular	irregular	JJ	B-ADJP	O
but	but	CC	O	O
reacts	react	VBZ	B-VP	O
2.5	2.5	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
pupil	pupil	NN	I-NP	O
irregular	irregular	JJ	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
iridectomy	iridectomy	NN	I-NP	O
.	.	.	O	O

Visual	Visual	JJ	B-NP	O
fields	field	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
eye	eye	NN	I-NP	O
slightly	slightly	RB	B-VP	O
adducted	adduct	VBN	I-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
without	without	IN	B-PP	O
diplopia	diplopia	NN	B-NP	O
.	.	.	O	O

Mild	Mild	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
abduction	abduction	NN	B-NP	O
and	and	CC	I-NP	O
adduction	adduction	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
without	without	IN	B-PP	O
diplopia	diplopia	NN	B-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
on	on	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
gaze	gaze	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
nystagmus	nystagmus	NN	I-NP	O
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
converge	converge	VB	I-VP	O
fully	fully	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
otherwise	otherwise	RB	B-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

Gag	Gag	NNP	B-NP	O
present	present	JJ	I-NP	O
.	.	.	O	O

Able	Able	NN	B-NP	O
to	to	TO	B-VP	O
swallow	swallow	VB	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

Motor	Motor	NNP	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
tone	tone	NN	I-NP	O
and	and	CC	O	O
power	power	NN	B-NP	O
to	to	TO	B-PP	O
confrontation	confrontation	NN	B-NP	O
,	,	,	O	O
symmetric	symmetric	JJ	B-NP	O
bulk	bulk	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

slight	slight	JJ	B-NP	O
slowing	slowing	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
clear	clear	JJ	I-NP	O
pronator	pronator	NN	I-NP	O
drift	drift	NN	I-NP	O
.	.	.	O	O

Tendon	Tendon	NN	B-NP	O
reflexes	reflex	NNS	I-NP	O
trace	trace	VBP	B-VP	O
brachialis	brachialis	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
biceps	bicep	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
triceps	tricep	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
knee	knee	NN	I-NP	I-protein
reflexes	reflex	NNS	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
ankle	ankle	NN	I-NP	O
jerks	jerk	NNS	I-NP	O
.	.	.	O	O

Equivocal	Equivocal	JJ	B-NP	O
toes	toe	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
vibration	vibration	NN	I-NP	O
sense	sense	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-SBAR	O
right	right	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
toes	toe	NNS	I-NP	O
,	,	,	O	O
intact	intact	JJ	B-NP	O
position	position	NN	I-NP	O
sense	sense	NN	I-NP	O
symmetric	symmetric	JJ	B-ADJP	O
.	.	.	O	O

Symmetric	Symmetric	JJ	B-NP	O
exam	exam	NN	I-NP	O
to	to	TO	B-PP	O
temperature	temperature	NN	B-NP	O
and	and	CC	I-NP	O
light	light	NN	I-NP	O
touch	touch	NN	I-NP	O
.	.	.	O	O
?	?	.	O	O

cerebellar	cerebellar	JJ	B-NP	O
exam	exam	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
dysmetria	dysmetria	NN	I-NP	O
on	on	IN	B-PP	O
finger	finger	NN	B-NP	O
to	to	TO	B-VP	O
nose	nose	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
Romberg	Romberg	NNP	B-NP	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
slight	slight	JJ	B-NP	O
swaying	swaying	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

Gait	Gait	NN	B-NP	O
slow	slow	JJ	B-ADJP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
steps	step	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
fairly	fairly	RB	B-ADJP	O
steady	steady	JJ	I-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
showed	show	VBD	B-VP	O
sodium	sodium	NN	B-NP	O
143	143	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.6	4.6	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
19	19	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
67	67	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8	8	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
222	222	CD	B-NP	I-protein
,	,	,	O	O
PT	PT	NN	B-NP	B-protein
17	17	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
2.3	2.3	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
32	32	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
changes	change	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
or	or	CC	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

Head	Head	NN	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
movement	movement	NN	B-NP	O
artifact	artifact	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
CVA	CVA	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

hypodensity	hypodensity	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
pons	pon	NNS	I-NP	O
but	but	CC	B-NP	O
likely	likely	RB	I-NP	O
artifact	artifact	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
vertical	vertical	JJ	B-NP	O
diplopia	diplopia	NN	I-NP	O
and	and	CC	I-NP	O
unsteadiness/imbalance	unsteadiness/imbalance	NN	I-NP	O
,	,	,	O	O
falling	fall	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
still	still	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
abduction	abduction	NN	I-NP	O
defect	defect	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
eye	eye	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
leftward	leftward	JJ	I-NP	O
gait	gait	NN	I-NP	O
unsteadiness	unsteadiness	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
vertical	vertical	JJ	I-NP	O
diplopia	diplopia	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
kept	keep	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
air	air	NN	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
significant	significant	JJ	I-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
open	open	JJ	I-NP	O
MRI	MRI	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
MRI	MRI	NNP	I-NP	O
in	in	IN	B-PP	O
Well	Well	NNP	B-NP	O
Deh	Deh	NNP	I-NP	O
Ny	Ny	NNP	I-NP	O
On	On	IN	B-PP	O
3	3	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
MRI	MRI	NN	B-NP	B-protein
with	with	IN	B-PP	O
particular	particular	JJ	B-NP	O
interest	interest	NN	I-NP	O
in	in	IN	B-PP	O
visualization	visualization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
fossa	fossa	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
or	or	CC	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
MRA	MRA	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
18	18	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
went	go	VBD	B-VP	O
down	down	RB	B-ADVP	O
slightly	slightly	RB	B-ADVP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
of	of	IN	B-PP	O
August	August	NNP	B-NP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
missed	miss	VBN	I-NP	O
dose	dose	NN	I-NP	O
earlier	earlier	RBR	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
17	17	CD	B-NP	O
of	of	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
reported	report	VBD	B-VP	O
feeling	feel	VBG	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
new	new	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
denied	deny	VBD	B-VP	O
further	further	JJ	B-NP	O
imbalance	imbalance	NN	I-NP	O
or	or	CC	O	O
vertical	vertical	JJ	B-NP	O
diplopia	diplopia	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
cerebral	cerebral	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
although	although	IN	B-SBAR	O
no	no	DT	B-NP	O
stroke	stroke	NN	I-NP	O
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
on	on	IN	B-PP	O
MRI	MRI	NN	B-NP	B-protein
,	,	,	O	O
involvement	involvement	NN	B-NP	O
of	of	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
suggested	suggest	VBD	B-VP	O
a	a	DT	B-NP	O
cerebral	cerebral	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
stem	stem	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
diplopia	diplopia	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
probably	probably	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
stroke/TIA	stroke/TIA	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
major	major	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
both	both	CC	O	O
small	small	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
and	and	CC	O	O
large	large	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
and	and	CC	O	O
cardioembolic	cardioembolic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
further	further	JJ	B-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
modification	modification	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP	B-NP	O
cardiac	cardiac	JJ	I-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
She	She	NNP	I-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
call	call	VB	I-VP	O
SMER	SMER	NN	B-NP	O
COMMUNITY	COMMUNITY	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
morning	morning	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Amitriptyline	Amitriptyline	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
diltiazem	diltiazem	NN	B-NP	O
CD	CD	NNP	B-NP	O
180	180	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Relafen	Relafen	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
70/30	70/30	CD	I-NP	I-protein
134	134	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcu	subcu	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
,	,	,	O	O
insulin	insulin	NN	B-NP	O
70/30	70/30	CD	I-NP	O
84	84	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
q.week	q.week	NN	I-NP	I-protein
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
18	18	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
further	further	JJ	B-NP	O
adjuster	adjuster	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
in	in	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

KCl	KCl	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
readjusted	readjust	VBN	B-VP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
for	for	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
MAIN	MAIN	NNP	B-NP	O
VALLEY	VALLEY	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
at	at	IN	B-PP	O
901-6641	901-6641	CD	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
of	of	IN	B-PP	O
May	May	NNP	B-NP	O
and	and	CC	O	O
scheduled	schedule	VBN	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
physician	physician	NN	I-NP	O
within	within	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
PT/INR	PT/INR	NN	I-NP	B-protein
check	check	NN	I-NP	O
for	for	IN	B-PP	O
readjustment	readjustment	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
DYLAN	DYLAN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
DELMONTE	DELMONTE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
RQ28	RQ28	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ELWOOD	ELWOOD	NNP	B-NP	O
BRASFIELD	BRASFIELD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TK19	TK19	NNP	I-NP	O
HC686/1303	HC686/1303	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
12477	12477	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

D3CXKT10OX	D3CXKT10OX	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/10/98	5/10/98	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/10/98	3/10/98	CD	B-NP	O

